Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heights
INDIANAPOLIS — Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quarter sales, or more than $200 million above what Wall Street had expected. Shares of the drugmaker soared 17% to…